In life sciences, we have a strong track record in domestic and cross-border mergers and acquisitions, helping our clients to monetise their assets through creative partnering with early-stage entrepreneurial and established companies, and by providing IP and tax advice.

The European Commission's report this September on the future of European competitiveness provides critical insights into the economic, regulatory, and technological challenges facing various industries, including the medical device and in vitro diagnostic (IVD) sectors. The report, undertaken by Mario Draghi for the Commission, highlights how medtech companies must navigate...

The European Commission's comprehensive report on the future of European competitiveness has identified critical challenges facing the pharmaceuticals industry as well as among a range of other sectors across Europe. The report, which has been presented by Mario Draghi, the former president of the European Central Bank President and ex-prime...

In health and social care, we advise on everything from the building and operating of hospitals and care homes to the provision of new methods of diagnosis and treatment.

Our specialist healthcare technology practice advises the companies and investors that are transforming the way therapies and patient services are delivered.

With offices in the US for over 16 years, our teams in Silicon Valley, San Francisco and New York have worked with more than 600 US companies at all stages of their international growth from emerging businesses to multinationals supporting their entire overseas legal needs. Our US offices do not...